Search | IOVS | ARVO Journals

Showing 1 – 20 of 34

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2025

Development and Evaluation of a Retrieval-Augmented Chatbot for Uveitis

Maxwell Singer; William Rojas-Carabali; Maria Vittoria Cicinelli; Carlos Cifuentes González; Jyotirmay Biswas; Alejandra de-la-Torre; Vishali Gupta; Jose S. Pulido; Rupesh Vijay Agrawal

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):3934.

ARVO Annual Meeting Abstract June 2025

Standardized Annotation Protocols for AI-Driven Detection of Diabetic Retinopathy in Ophthalmic Imaging

MONA DUGGAL; Sonam Kumar; Richa Singh; Mayank Vatsa; Mahapara Khurshid; Harsh Rastogi; Anshul Chauhan; Suklenmung Buragohain; Anasuya Bhattacharjee; Limalemla Jamir; Harsha Bhattacharjee; Vishali Gupta

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):5397.

ARVO Annual Meeting Abstract June 2025

Final results of the phase 2 BETTER trial using intravitreal ISTH0036, a selective TGF-β2 blocking antisense in nAMD and DME

Marion Ronit Munk; Vishali Gupta; Matthias Bolz; Rupert Strauss; Andreas Wedrich; Manpreet Brar; Muna Bhende; Dilraj Grewal; Rene Rückert

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):3677.

ARVO Annual Meeting Abstract June 2025

A Computational Definition for Tubercular Uveitis: Integrating the Standardisation of Uveitis Nomenclature Criteria into The Ocular Autoimmune Systemic Inflammatory Infectious Study Registry

Aedann See; Yan Guex-Crosier; Ariel Schlaen; Ranju Kharel; Kalpana Babu; Manisha Aggarwal; Vishali Gupta; Atul Arora; Anna Utami; Alejandra de-la-Torre; Apoorva Ayachit; Alok Sen; Rina La Distia Nora; Sofia Androudi; John H Kempen; Cristhian Urzua; Jyotirmay Biswas; Gazal Patnaik; Chitaranjan Mishra; Padmamalini Mahendradas; Debra Goldstein; Anadi Katri; Alay Banker; Rupesh Vijay Agrawal; William Rojas-Carabali

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):1362.

ARVO Annual Meeting Abstract June 2024

Unleashing the Power of AI: Enhancing Surgical Planning and Outcomes in Ophthalmology

Vishali Gupta

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3.

ARVO Annual Meeting Abstract June 2024

First results of the phase 2 BETTER trial using intravitreal ISTH0036, a selective TGF-β2 blocking antisense in AMD and DME

Marion Ronit Munk; Vishali Gupta; Matthias Bolz; Rupert Strauss; Andreas Wedrich; Manpreet Brar; Muna Bhende; Rene Rückert

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3309.

ARVO Annual Meeting Abstract June 2024

Vitreous fluid transcriptome: a potential role in diagnosis of Ocular Tuberculosis.

KRITIKA KAKKAR; DR. VISHALI GUPTA; DR. REEMA BANSAL; DR. RAHUL KUMAR; Sushree Sangita Kar; DR. PRABHDEEP KAUR; DR. SUMEDHA SHARMA; DR. SUBRATA PATRA; DR. ARINDAM MAITRA; DR. INDU VERMA

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3170.

ARVO Annual Meeting Abstract June 2024

HLADRB1-Associated Childhood Uveitis : A Novel Autoimmune variant of Tubulointerstitial Nephritis and Uveitis (TINU)

Vishali Gupta; Atul Arora; Ankur Jindal; Igor Kozak; Kamal Kishore; Rupesh Agrawal

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3014.

ARVO Annual Meeting Abstract June 2024

Longitudinal Analysis of Uveitis: Diagnostic Trends and Disease Trajectory Over a Decade

Kamal Kishore; Gunjan Sharma; Atul Arora; William Rojas-Carabali; Bernett Lee; Amod Gupta; DR. REEMA BANSAL; Mohit Dogra; Deeksha Katoch; Aman Sharma; Ankur Jindal; Deepti Suri; Surjit Singh; Rupesh Vijay Agrawal; DR. VISHALI GUPTA

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6452.

ARVO Annual Meeting Abstract June 2024

Predicting Uveitis Recurrence Risk Using Baseline Clinical Characteristics: Insights from the OASIS Registry

William Rojas-Carabali; Carlos Cifuentes González; Joyce Lim; Alejandra de-la-Torre; Vishali Gupta; Rupesh Vijay Agrawal; Bernett Lee

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5048.

ARVO Annual Meeting Abstract June 2023

Global Insights into Ocular Inflammation: Results from the OASIS Clinical Registry in Four Tropical Countries

Xin Wei; Kevin Jerrold Chan; William Rojas-Carabali; Carlos Cifuentes-Gonzalez; teck kwong bernett lee; John H Kempen; Edmund Tsui; Alejandra de-la-Torre; Vishali Gupta; Rupesh Vijay Agrawal

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4835.

ARVO Annual Meeting Abstract June 2023

Validation of online Collaborative Ocular Tuberculosis Study (COTS) Calculator as a guide to initiate antitubercular therapy in patients with ocular tuberculosis.

Ludi Zhang; Rupesh Vijay Agrawal; teck kwong bernett lee; Shannon Sheriel Choo; Wen Jun Song; Vishali Gupta

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4847.

ARVO Annual Meeting Abstract June 2023

Retinal Vascularity Index in Retinal Vein Occlusion using new purpose-built semi-automated software.

Vishali Gupta; Atul Arora; Rupesh Vijay Agrawal

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1768.

ARVO Annual Meeting Abstract June 2022

Anti-Tubercular Therapy in the Treatment of Tubercular Uveitis

Rupesh Vijay Agrawal; Bjorn Betzler; Ikhwanuliman Putera; Rina La Distia Nora; Ilaria Testi; Onn Min Kon; John H Kempen; Carlos Pavesio; Vishali Gupta

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3216 – A0442.

ARVO Annual Meeting Abstract June 2021

Brolucizumab for the treatment of visual impairment due to diabetic macular edema: 52-week results from the KITE and KESTREL studies

David M Brown; Sebastian Wolf; Justus Garweg; Francesco Bandello; Andres Emanuelli; Jose Juan Escobar Barranco; Joao Figueira; Vishali Gupta; Nor Fariza Ngah; Gerald Liew; Raman Tuli; Lixin Wang; Emmanuel Bouillaud; Eric Souied

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1045.

ARVO Annual Meeting Abstract June 2020

Intraocular lymphoma: Biomarkers revisited.

surya Prakash sharma; Aman Kumar; Vishali Gupta; ANIRUDDHA AGARWAL; Nalini Gupta; Reema bansal; Raman deep Singh; Mohit dogra; Nirbhai Singh; Deeksha Katoch; Shobha Sehgal

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):35.

ARVO Annual Meeting Abstract July 2019

Effect of axial length on intraocular VEGF levels in eyes with Diabetic Retinopathy

ASHISH KULSHRESTHA; Aniruddha Agarwal; Basav Raj Tigari; ankur singh; Bruttendu Moharana; Vishali Gupta; Mangat Ram Dogra; Jagat Ram; Ramandeep Singh

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2676.

ARVO Annual Meeting Abstract July 2019

Recommendations for the Diagnostic of vitreoretinal Lymphoma (VRL)

Manfred Zierhut; Rupesh Vijay Agrawal; Denise Carbonell; Sarakshi Mahajan; Tanja Berger; Bianka Sobolewska; Vishali Gupta; Soon Phaik Chee

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3544.

ARVO Annual Meeting Abstract July 2019

Mycobacterium tuberculosis (M.tb) antibody and antigen biomarkers for rapid diagnosis of intra-ocular tuberculosis

Kamaljit Kaur; Michelle B Ryndak; Aniruddha Agarwal; Indu Verma; Vishali Gupta; Suman Laal

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):827.

ARVO Annual Meeting Abstract July 2019

Collaborative Ocular Tuberculosis Study (COTS) consensus guidelines on initiating antitubercular therapy in presumed tubercular retinal vasculitis

Rupesh Vijay Agrawal; Ilaria Testi; Sarakshi Mahajan; Dhananjay Raje; Aniruddha Agarwal; Dinesh Gunasekeran; John H Kempen; Quan Dong Nguyen; Carlos Pavesio; Vishali Gupta

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):861.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Development and Evaluation of a Retrieval-Augmented Chatbot for Uveitis

Standardized Annotation Protocols for AI-Driven Detection of Diabetic Retinopathy in Ophthalmic Imaging

Final results of the phase 2 BETTER trial using intravitreal ISTH0036, a selective TGF-β2 blocking antisense in nAMD and DME

A Computational Definition for Tubercular Uveitis: Integrating the Standardisation of Uveitis Nomenclature Criteria into The Ocular Autoimmune Systemic Inflammatory Infectious Study Registry

Unleashing the Power of AI: Enhancing Surgical Planning and Outcomes in Ophthalmology

First results of the phase 2 BETTER trial using intravitreal ISTH0036, a selective TGF-β2 blocking antisense in AMD and DME

Vitreous fluid transcriptome: a potential role in diagnosis of Ocular Tuberculosis.

HLADRB1-Associated Childhood Uveitis : A Novel Autoimmune variant of Tubulointerstitial Nephritis and Uveitis (TINU)

Longitudinal Analysis of Uveitis: Diagnostic Trends and Disease Trajectory Over a Decade

Predicting Uveitis Recurrence Risk Using Baseline Clinical Characteristics: Insights from the OASIS Registry

Global Insights into Ocular Inflammation: Results from the OASIS Clinical Registry in Four Tropical Countries

Validation of online Collaborative Ocular Tuberculosis Study (COTS) Calculator as a guide to initiate antitubercular therapy in patients with ocular tuberculosis.

Retinal Vascularity Index in Retinal Vein Occlusion using new purpose-built semi-automated software.

Anti-Tubercular Therapy in the Treatment of Tubercular Uveitis

Brolucizumab for the treatment of visual impairment due to diabetic macular edema: 52-week results from the KITE and KESTREL studies

Intraocular lymphoma: Biomarkers revisited.

Effect of axial length on intraocular VEGF levels in eyes with Diabetic Retinopathy

Recommendations for the Diagnostic of vitreoretinal Lymphoma (VRL)

Mycobacterium tuberculosis (M.tb) antibody and antigen biomarkers for rapid diagnosis of intra-ocular tuberculosis

Collaborative Ocular Tuberculosis Study (COTS) consensus guidelines on initiating antitubercular therapy in presumed tubercular retinal vasculitis

To View More...

You must be signed into an individual account to use this feature.